Skip to main content

Table 2 Genotypes and PAVM

From: A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark

Genotype

Number of patients (percentage of the total population n = 180)

Patients with PAVM identified (percentage of genotype subgroup)

HHT1

89 (49%)

38 (42.7%)

HHT2

67 (37%)

12 (17.9%)

JP-HHT

15 (8%)

5 (33%)

Clinical HHT

9 (5%)

2 (22.5%)